Exelixis | Capital Ordinário



Ordinary Share Capital Alterar Data
Acadia Pharmaceuticals USD 16K 0 2025-03
Agios Pharmaceuticals USD 74K 1000 2025-03
Amgen USD 33.58B 45M 2025-03
AstraZeneca USD 388M 0 2025-03
Bayer EUR 2.52B 0 2025-03
BioMarin Pharmaceutical USD 192K 1000 2025-03
Bristol-Myers Squibb USD 292M 0 2025-03
Cytokinetics USD 119K 1000 2025-03
Eisai JPY 44.99B 0 2025-03
Eli Lilly USD 592.6M 200K 2025-03
Exelixis USD 275K 7K 2025-04
Genmab DKK 10M 56M 2025-03
Glaxosmithkline GBP 1.35B 0 2024-12
Incyte USD 193K 0 2025-03
Ionis Pharmaceuticals USD 159K 1000 2025-03
MacroGenics USD 628K 1000 2024-12
Merck USD 1.79B 0 2025-03
Moderna USD 38.7K 100 2025-03
Neurocrine Biosciences USD 100K 0 2024-12
Novartis USD 793M 0 2024-12
Pfizer USD 481M 1000K 2025-03
Takeda JPY 1.69T 25M 2025-03
Ultragenyx Pharmaceutical USD 92K 0 2024-12
Xencor USD 712K 9K 2025-03



Exelixis Capital Ordinário - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.